A detailed history of True Wealth Design, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, True Wealth Design, LLC holds 104 shares of AZN stock, worth $6,986. This represents 0.0% of its overall portfolio holdings.

Number of Shares
104
Previous 100 4.0%
Holding current value
$6,986
Previous $7.8 Million 3.9%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$76.67 - $87.62 $306 - $350
4 Added 4.0%
104 $8.1 Million
Q2 2024

Aug 14, 2024

BUY
$66.81 - $80.83 $2,271 - $2,748
34 Added 51.52%
100 $7.8 Million
Q1 2024

May 14, 2024

BUY
$61.03 - $69.57 $1,952 - $2,226
32 Added 94.12%
66 $4.47 Million
Q4 2023

Feb 14, 2024

BUY
$61.89 - $69.28 $185 - $207
3 Added 9.68%
34 $2.29 Million
Q4 2022

Feb 15, 2023

BUY
$54.21 - $70.44 $1,680 - $2,183
31 New
31 $2.1 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $208B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track True Wealth Design, LLC Portfolio

Follow True Wealth Design, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of True Wealth Design, LLC, based on Form 13F filings with the SEC.

News

Stay updated on True Wealth Design, LLC with notifications on news.